Last checked at 23 Feb 2011 13:30
Plant Health Care plc
Wednesday, 23 February 2011
PLANT HEALTH CARE plc (THE "COMPANY")
Additional Listing and Directors' Shareholdings
On 22 February, the Company approved the allotment of 71,516 ordinary shares of 1p ("Ordinary Shares") to the following non-executive directors, in accordance with the Company's existing contractual arrangements, which comprise part of the non-executive directors' remuneration packages and are payable in lieu of a part of their fees. The shares were allotted at 61p per share, calculated at the closing middle market price derived from the Daily Official List on 21 February 2011.
Non-executive director | Value of remuneration used to purchase shares | Number of Ordinary Shares allotted |
Dominik Koechlin | £12,875.00 | 21,107 |
Sam Wauchope | £10,250.00 | 16,803 |
David Buckeridge | £10,250.00 | 16,803 |
Jeremy Scudamore | £10,250.00 | 16,803 |
TOTAL: | 71,516 |
Following the above-mentioned allotments, the beneficial interests of the non-executive directors in the enlarged Ordinary Share capital of the Company are as shown below:
Name | Ordinary Share holding | Percentage of enlarged Ordinary Share capital | Share Options |
Dominik Koechlin | 178,591 | 0.34% | N/A |
Sam Wauchope | 106,229 | 0.20% | N/A |
David Buckeridge | 105,355 | 0.20% | N/A |
Jeremy Scudamore | 102,854 | 0.19% | N/A |
Application has been made for 71,516 Ordinary Shares (the 'New Shares') to be admitted to trading on AIM and admission is expected to occur on 28 February 2011. The New Shares will rank pari passu with the Company's existing Ordinary Shares.
Following admission of the New Shares, the total issued share capital of the Company will be 53,031,789 Ordinary Shares, all of which have voting rights.
The above figure (53,031,798) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Plant Health Care plc under the FSA's Disclosure and Transparency Rules.
-: Ends :-
Enquiries:
Andrew C. Wood FCIS
Company Secretary
020 8866 5702
Evolution Securities Limited
Tim Worlledge/Tim Redfern
Tel: 020 7071 4300
Tavistock Communications
Jeremy Carey/Matt Ridsdale
Tel: 020 7920 3150